Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Other Operating Expenses (2018 - 2024)

Historic Other Operating Expenses for iBio (IBIO) over the last 6 years, with Q1 2024 value amounting to $1.0 million.

  • iBio's Other Operating Expenses changed N/A to $1.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2024, iBio's Other Operating Expenses is $1.0 million.
  • Over the past 5 years, iBio's Other Operating Expenses peaked at $1.0 million during Q1 2024, and registered a low of -$193000.0 during Q2 2021.
  • Moreover, its 3-year median value for Other Operating Expenses was -$185000.0 (2020), whereas its average is -$39888.9.
  • In the last 5 years, iBio's Other Operating Expenses plummeted by 818.71% in 2020 and then surged by 6553.67% in 2021.
  • Over the past 3 years, iBio's Other Operating Expenses (Quarter) stood at -$177000.0 in 2020, then surged by 65.54% to -$61000.0 in 2021, then skyrocketed by 1739.34% to $1.0 million in 2024.
  • Its last three reported values are $1.0 million in Q1 2024, -$61000.0 for Q4 2021, and -$189000.0 during Q3 2021.